000 01046 a2200265 4500
005 20250514031030.0
264 0 _c20020925
008 200209s 0 0 eng d
022 _a0176-3679
024 7 _a10.1055/s-2002-25029
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEngfer, A
245 0 0 _aSoyka M, Bottlender R, Möller H-J; Epidemiological evidence for a low abuse potential of zolpidem; Pharmacopsychiatry 2000, 33: 138 - 141.
_h[electronic resource]
260 _bPharmacopsychiatry
_cMar 2002
300 _a81; author reply 81-2 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aHumans
650 0 4 _aHypnotics and Sedatives
_xadverse effects
650 0 4 _aPyridines
_xadverse effects
650 0 4 _aSubstance Withdrawal Syndrome
_xpsychology
650 0 4 _aSubstance-Related Disorders
_xepidemiology
650 0 4 _aZolpidem
773 0 _tPharmacopsychiatry
_gvol. 35
_gno. 2
_gp. 81; author reply 81-2
856 4 0 _uhttps://doi.org/10.1055/s-2002-25029
_zAvailable from publisher's website
999 _c11854053
_d11854053